Real Estate - Services
Compare Stocks
4 / 10Stock Comparison
ALBT vs WELL vs VTR vs CELC
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
Biotechnology
ALBT vs WELL vs VTR vs CELC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Real Estate - Services | REIT - Healthcare Facilities | REIT - Healthcare Facilities | Biotechnology |
| Market Cap | $379K | $149.25B | $41.15B | $5.66B |
| Revenue (TTM) | $1M | $11.63B | $6.13B | $0.00 |
| Net Income (TTM) | $-19M | $1.43B | $260M | $-163M |
| Gross Margin | 25.7% | 39.1% | -4.3% | — |
| Operating Margin | -5.1% | 4.4% | 13.4% | — |
| Forward P/E | — | 78.4x | 118.0x | — |
| Total Debt | $8M | $21.38B | $13.22B | $98M |
| Cash & Equiv. | $3M | $5.03B | $741M | $23M |
ALBT vs WELL vs VTR vs CELC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Avalon GloboCare Co… (ALBT) | 100 | 0.2 | -99.8% |
| Welltower Inc. (WELL) | 100 | 420.4 | +320.4% |
| Ventas, Inc. (VTR) | 100 | 247.6 | +147.6% |
| Celcuity Inc. (CELC) | 100 | 1343.4 | +1243.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ALBT vs WELL vs VTR vs CELC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ALBT lags the leaders in this set but could rank higher in a more targeted comparison.
WELL carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- 35.8% FFO/revenue growth vs CELC's -73.2%
- Better valuation composite
VTR is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 1 yrs, beta 0.01, yield 2.1%
- Beta 0.01, yield 2.1%, current ratio 0.96x
- Beta 0.01 vs CELC's 1.71
CELC is the clearest fit if your priority is long-term compounding.
- 8.1% 10Y total return vs WELL's 223.1%
- +11.8% vs ALBT's -88.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs CELC's -73.2% | |
| Value | Better valuation composite | |
| Quality / Margins | 12.3% margin vs ALBT's -13.6% | |
| Stability / Safety | Beta 0.01 vs CELC's 1.71 | |
| Dividends | 1.3% yield, 2-year raise streak, vs VTR's 2.1%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +11.8% vs ALBT's -88.9% | |
| Efficiency (ROA) | 2.3% ROA vs ALBT's -207.3%, ROIC 0.5% vs -26.6% |
ALBT vs WELL vs VTR vs CELC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ALBT vs WELL vs VTR vs CELC — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
WELL leads in 2 of 6 categories
CELC leads 1 • VTR leads 1 • ALBT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
WELL leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL and CELC operate at a comparable scale, with $11.6B and $0 in trailing revenue. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to ALBT's -13.6%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1M | $11.6B | $6.1B | $0 |
| EBITDAEarnings before interest/tax | -$7M | $2.8B | $2.3B | -$159M |
| Net IncomeAfter-tax profit | -$19M | $1.4B | $260M | -$163M |
| Free Cash FlowCash after capex | -$5M | $2.5B | $1.4B | -$145M |
| Gross MarginGross profit ÷ Revenue | +25.7% | +39.1% | -4.3% | — |
| Operating MarginEBIT ÷ Revenue | -5.1% | +4.4% | +13.4% | — |
| Net MarginNet income ÷ Revenue | -13.6% | +12.3% | +4.2% | — |
| FCF MarginFCF ÷ Revenue | -3.9% | +21.9% | +22.4% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.4% | +40.3% | +22.0% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +96.6% | +22.5% | 0.0% | -31.4% |
Valuation Metrics
Evenly matched — ALBT and VTR each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 153.3x trailing earnings, WELL trades at a 4% valuation discount to VTR's 160.3x P/E. On an enterprise value basis, VTR's 24.3x EV/EBITDA is more attractive than WELL's 66.4x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $379,329 | $149.2B | $41.1B | $5.7B |
| Enterprise ValueMkt cap + debt − cash | $5M | $165.6B | $53.6B | $5.7B |
| Trailing P/EPrice ÷ TTM EPS | -0.05x | 153.25x | 160.26x | -46.19x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 78.42x | 118.01x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 66.40x | 24.31x | — |
| Price / SalesMarket cap ÷ Revenue | 0.28x | 13.99x | 7.05x | — |
| Price / BookPrice ÷ Book value/share | 0.05x | 3.35x | 3.18x | 44.60x |
| Price / FCFMarket cap ÷ FCF | — | 52.41x | 31.25x | — |
Profitability & Efficiency
WELL leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
WELL delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-179 for CELC. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to ALBT's 1.10x. On the Piotroski fundamental quality scale (0–9), ALBT scores 7/9 vs CELC's 1/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -109.2% | +3.5% | +2.1% | -179.0% |
| ROA (TTM)Return on assets | -2.1% | +2.3% | +1.0% | -58.0% |
| ROICReturn on invested capital | -26.6% | +0.5% | +2.5% | -50.3% |
| ROCEReturn on capital employed | -47.1% | +0.6% | +3.2% | -58.0% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 6 | 1 |
| Debt / EquityFinancial leverage | 1.10x | 0.49x | 1.05x | 0.85x |
| Net DebtTotal debt minus cash | $5M | $16.3B | $12.5B | $75M |
| Cash & Equiv.Liquid assets | $3M | $5.0B | $741M | $23M |
| Total DebtShort + long-term debt | $8M | $21.4B | $13.2B | $98M |
| Interest CoverageEBIT ÷ Interest expense | -2.02x | 0.26x | 1.40x | -5.02x |
Total Returns (Dividends Reinvested)
CELC leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CELC five years ago would be worth $48,161 today (with dividends reinvested), compared to $29 for ALBT. Over the past 12 months, CELC leads with a +1184.0% total return vs ALBT's -88.9%. The 3-year compound annual growth rate (CAGR) favors CELC at 140.6% vs ALBT's -75.7% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -67.6% | +14.3% | +12.6% | +30.0% |
| 1-Year ReturnPast 12 months | -88.9% | +42.7% | +33.9% | +1184.0% |
| 3-Year ReturnCumulative with dividends | -98.6% | +189.5% | +94.2% | +1292.0% |
| 5-Year ReturnCumulative with dividends | -99.7% | +202.3% | +74.8% | +381.6% |
| 10-Year ReturnCumulative with dividends | -99.6% | +223.1% | +65.0% | +814.7% |
| CAGR (3Y)Annualised 3-year return | -75.7% | +42.5% | +24.8% | +140.6% |
Risk & Volatility
VTR leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
VTR is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than CELC's 1.71 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 97.8% from its 52-week high vs ALBT's 8.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.11x | 0.13x | 0.01x | 1.71x |
| 52-Week HighHighest price in past year | $4.74 | $219.59 | $88.50 | $151.02 |
| 52-Week LowLowest price in past year | $0.34 | $142.65 | $61.76 | $9.51 |
| % of 52W HighCurrent price vs 52-week peak | +8.5% | +97.0% | +97.8% | +86.6% |
| RSI (14)Momentum oscillator 0–100 | 42.4 | 60.2 | 56.2 | 63.4 |
| Avg Volume (50D)Average daily shares traded | 8.4M | 2.6M | 3.4M | 800K |
Analyst Outlook
Evenly matched — WELL and VTR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: WELL as "Buy", VTR as "Buy", CELC as "Buy". Consensus price targets imply 6.3% upside for WELL (target: $227) vs -4.6% for CELC (target: $125). For income investors, VTR offers the higher dividend yield at 2.15% vs WELL's 1.30%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $226.50 | $90.80 | $124.75 |
| # AnalystsCovering analysts | — | 34 | 32 | 9 |
| Dividend YieldAnnual dividend ÷ price | — | +1.3% | +2.1% | — |
| Dividend StreakConsecutive years of raises | — | 2 | 1 | — |
| Dividend / ShareAnnual DPS | — | $2.76 | $1.86 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% |
WELL leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CELC leads in 1 (Total Returns). 2 tied.
ALBT vs WELL vs VTR vs CELC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ALBT or WELL or VTR or CELC a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus 6. 2% for Avalon GloboCare Corp. (ALBT). Welltower Inc. (WELL) offers the better valuation at 153. 3x trailing P/E (78. 4x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ALBT or WELL or VTR or CELC?
On trailing P/E, Welltower Inc.
(WELL) is the cheapest at 153. 3x versus Ventas, Inc. at 160. 3x. On forward P/E, Welltower Inc. is actually cheaper at 78. 4x.
03Which is the better long-term investment — ALBT or WELL or VTR or CELC?
Over the past 5 years, Celcuity Inc.
(CELC) delivered a total return of +381. 6%, compared to -99. 7% for Avalon GloboCare Corp. (ALBT). Over 10 years, the gap is even starker: CELC returned +814. 7% versus ALBT's -99. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ALBT or WELL or VTR or CELC?
By beta (market sensitivity over 5 years), Ventas, Inc.
(VTR) is the lower-risk stock at 0. 01β versus Celcuity Inc. 's 1. 71β — meaning CELC is approximately 17902% more volatile than VTR relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 110% for Avalon GloboCare Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — ALBT or WELL or VTR or CELC?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus 6. 2% for Avalon GloboCare Corp. (ALBT). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -430. 8% for Avalon GloboCare Corp.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ALBT or WELL or VTR or CELC?
Welltower Inc.
(WELL) is the more profitable company, earning 8. 8% net margin versus -592. 7% for Avalon GloboCare Corp. — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VTR leads at 14. 2% versus -369. 6% for ALBT. At the gross margin level — before operating expenses — WELL leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ALBT or WELL or VTR or CELC more undervalued right now?
On forward earnings alone, Welltower Inc.
(WELL) trades at 78. 4x forward P/E versus 118. 0x for Ventas, Inc. — 39. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WELL: 6. 3% to $226. 50.
08Which pays a better dividend — ALBT or WELL or VTR or CELC?
In this comparison, VTR (2.
1% yield), WELL (1. 3% yield) pay a dividend. ALBT, CELC do not pay a meaningful dividend and should not be held primarily for income.
09Is ALBT or WELL or VTR or CELC better for a retirement portfolio?
For long-horizon retirement investors, Ventas, Inc.
(VTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 2. 1% yield). Both have compounded well over 10 years (VTR: +65. 0%, ALBT: -99. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ALBT and WELL and VTR and CELC?
These companies operate in different sectors (ALBT (Real Estate) and WELL (Real Estate) and VTR (Real Estate) and CELC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ALBT is a small-cap quality compounder stock; WELL is a mid-cap high-growth stock; VTR is a mid-cap high-growth stock; CELC is a small-cap quality compounder stock. WELL, VTR pay a dividend while ALBT, CELC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.